Clinical Trial Update: An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating rh PSMA-7.3 PET/MRI as an imaging agent to detect recurrent prostate cancer and assist in radiotherapy planning; the trial status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• rh PSMA-7.3 PET/MRI (rh PSMA-7.3 radiopharmaceutical imaging tracer)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma | Phase 1 | Status: COMPLETED